{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:13:50Z","timestamp":1791918830952,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,14]],"date-time":"2018-04-14T00:00:00Z","timestamp":1523664000000},"content-version":"vor","delay-in-days":103,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115568"],"award-info":[{"award-number":["115568"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007333","name":"Alzheimer's Disease Neuroimaging Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007333","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AG024904"],"award-info":[{"award-number":["U01 AG024904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-12-2-0012"],"award-info":[{"award-number":["W81XWH-12-2-0012"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Clinical"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/j.nicl.2018.04.016","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T12:59:45Z","timestamp":1523883585000},"page":"190-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets"],"prefix":"10.1016","volume":"19","author":[{"given":"Carles","family":"Falcon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Tucholka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma C.","family":"Mont\u00e9-Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Cacciaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9gory","family":"Operto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Rami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Domingo","family":"Gispert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Molinuevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nicl.2018.04.016_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058816","article-title":"Atrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trials","volume":"8","author":"Andrews","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nicl.2018.04.016_bb0010","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3233\/JAD-140624","article-title":"Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease","volume":"42","author":"Antonell","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nicl.2018.04.016_bb0015","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3233\/JAD-121906","article-title":"Cognitive reserve proxies relate to gray matter loss in cognitively healthy elderly with abnormal cerebrospinal fluid amyloid-\u03b2 levels","volume":"35","author":"Arenaza-Urquijo","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nicl.2018.04.016_bb0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuroimage.2007.07.007","article-title":"A fast diffeomorphic image registration algorithm","volume":"38","author":"Ashburner","year":"2007","journal-title":"NeuroImage"},{"key":"10.1016\/j.nicl.2018.04.016_bb0025","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/ana.22333","article-title":"Amyloid-\u03b2 associated cortical thinning in clinically normal elderly","volume":"69","author":"Becker","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nicl.2018.04.016_bb0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1212\/WNL.0b013e3181c918b5","article-title":"Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia","volume":"74","author":"Bourgeat","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2018.04.016_bb0035","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00401-013-1153-2","article-title":"Amyloid-?? may be released from non-junctional varicosities of axons generated from abnormal tau-containing brainstem nuclei in sporadic Alzheimer's disease: a hypothesis","volume":"126","author":"Braak","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nicl.2018.04.016_bb0040","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.nicl.2013.02.006","article-title":"Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease","volume":"2","author":"Ch\u00e9telat","year":"2013","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.nicl.2018.04.016_bb0045","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1093\/brain\/awq187","article-title":"Larger temporal volume in elderly with high versus low beta-amyloid deposition","volume":"133","author":"Ch\u00e9telat","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nicl.2018.04.016_bb0050","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/cercor\/bhn113","article-title":"The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals","volume":"19","author":"Dickerson","year":"2009","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.nicl.2018.04.016_bb0055","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/jamaneurol.2013.1062","article-title":"Cross-sectional and longitudinal analysis of the relationship between A\u03b2 deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease","volume":"70","author":"Dor\u00e9","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nicl.2018.04.016_bb0060","doi-asserted-by":"crossref","unstructured":"Driscoll, I., Zhou, Y., An, Y., Sojkova, J., Davatzikos, C., Michael, A., n.d. Lack of association between 11 C-PiB and longitudinal brain atrophy in non-demented older individuals. Neurobiol. Aging 32, 2123\u20132130. doi:https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.12.008.Lack.","DOI":"10.1016\/j.neurobiolaging.2009.12.008"},{"key":"10.1016\/j.nicl.2018.04.016_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria","author":"Dubois","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nicl.2018.04.016_bb0070","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.21559","article-title":"Decreased cerebrospinal fluid A?? 42 correlates with brain atrophy in cognitively normal elderly","volume":"65","author":"Fagan","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nicl.2018.04.016_bb0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.nicl.2018.04.016_bb0080","article-title":"The roots of Alzheimer's disease: are high-expanding cortical areas preferentially targeted?","author":"Fjell","year":"2014","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.nicl.2018.04.016_bb0085","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pneurobio.2014.02.004","article-title":"What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus","volume":"117","author":"Fjell","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nicl.2018.04.016_bb0090","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1523\/JNEUROSCI.3785-09.2010","article-title":"CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease","volume":"30","author":"Fjell","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nicl.2018.04.016_bb0095","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.biopsych.2011.02.017","article-title":"Cognitively preserved subjects with transitional cerebrospinal fluid \u00df-amyloid 1-42 values have thicker cortex in Alzheimer's disease vulnerable areas","volume":"70","author":"Fortea","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nicl.2018.04.016_bb0100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archneurol.2007.27","article-title":"Brain volume decline in aging: evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve","volume":"65","author":"Fotenos","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nicl.2018.04.016_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2015.06.027","article-title":"Nonlinear cerebral atrophy patterns across the Alzheimer's disease continuum: impact of APOE4 genotype","volume":"36","author":"Gispert","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2018.04.016_bb0110","article-title":"Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease","volume":"12","author":"Gispert","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nicl.2018.04.016_bb0115","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.biopsych.2013.11.032","article-title":"Phosphorylated tau-A\u03b242 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer's disease in multiplex immunoassay panels of cerebrospinal fluid","volume":"75","author":"Harari","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nicl.2018.04.016_bb0120","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.neurobiolaging.2010.04.033","article-title":"Sex and age differences in atrophic rates: an ADNI study with n\u202f=\u202f1368 MRI scans","volume":"31","author":"Hua","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2018.04.016_bb0125","first-page":"1","article-title":"The transitional association between \u03b2-amyloid pathology and regional brain atrophy","author":"Insel","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nicl.2018.04.016_bb0130","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1212\/WNL.0000000000002683","article-title":"Accelerating rates of cognitive decline and imaging markers associated with \u03b2-amyloid pathology","volume":"86","author":"Insel","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2018.04.016_bb0135","series-title":"2018 NIA-AA Research Framework to Investigate the Alzheimer's Disease Continuum Background: Rationale for Updating 2011 NIA-AA Guidelines for Alzheimer's Disease","author":"Jack","year":"2017"},{"key":"10.1016\/j.nicl.2018.04.016_bb0140","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/awq277","article-title":"Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease","volume":"133","author":"Jack","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nicl.2018.04.016_bb0145","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S1474-4422(14)70194-2","article-title":"Age-specific population frequencies of cerebral \u03b2-amyloidosis and neurodegeneration among people with normal cognitive function aged 50\u201389\u202fyears: a cross-sectional study","volume":"13","author":"Jack","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nicl.2018.04.016_bb0150","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ana.23908","article-title":"Comparing positron emission tomography imaging and cerebrospinal fluid measurements of \u03b2-amyloid","volume":"74","author":"Landau","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nicl.2018.04.016_bb0155","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.neurobiolaging.2014.07.046","article-title":"Disentangling normal aging from Alzheimer's disease in structural magnetic resonance images","volume":"36","author":"Lorenzi","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2018.04.016_bb0160","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jalz.2013.01.010","article-title":"CSF biomarker variability in the Alzheimer's Association quality control program","volume":"9","author":"Mattsson","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nicl.2018.04.016_bb0165","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/brain\/awu043","article-title":"Association of brain amyloid-\u03b2 with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment","volume":"137","author":"Mattsson","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.nicl.2018.04.016_bb0170","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3233\/JAD-130203","article-title":"The AD-CSF-index discriminates Alzheimer's disease patients from healthy controls: a validation study","volume":"36","author":"Molinuevo","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nicl.2018.04.016_bb0175","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/j.neurobiolaging.2013.02.013","article-title":"Different patterns of gray matter atrophy in early- and late-onset Alzheimer's disease","volume":"34","author":"M\u00f6ller","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2018.04.016_bb0180","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/brain\/awn320","article-title":"Episodic memory loss is related to hippocampal-mediated \u03b2-amyloid deposition in elderly subjects","volume":"132","author":"Mormino","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.nicl.2018.04.016_bb0185","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1385\/JMN:17:2:101","article-title":"Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease","volume":"17","author":"Morris","year":"2001","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.nicl.2018.04.016_bb0190","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nicl.2018.04.016_bb0195","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.neurobiolaging.2010.04.029","article-title":"Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort","volume":"31","author":"Risacher","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2018.04.016_bb0200","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ana.22315","article-title":"Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid A??1-42","volume":"68","author":"Schott","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nicl.2018.04.016_bb0205","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nicl.2018.04.016_bb0210","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nicl.2018.04.016_bb0215","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/archneurol.2009.272","article-title":"Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition","volume":"66","author":"Storandt","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nicl.2018.04.016_bb0220","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11682-012-9171-6","article-title":"CSF biomarker associations with change in hippocampal volume and precuneus thickness: implications for the Alzheimer's pathological cascade","volume":"6","author":"Stricker","year":"2012","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.nicl.2018.04.016_bb0225","first-page":"1","article-title":"Longitudinal cerebrospinal fluid biomarker changes in preclinical Alzheimer disease during middle age","author":"Sutphen","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nicl.2018.04.016_bb0230","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1001\/jamaneurol.2015.0202","article-title":"Cerebrospinal fluid markers of neurodegeneration and rates of brain atrophy in early Alzheimer disease","volume":"72","author":"Tarawneh","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nicl.2018.04.016_bb0235","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.exger.2013.10.002","article-title":"Mediterranean diet habits in older individuals: associations with cognitive functioning and brain volumes","volume":"48","author":"Titova","year":"2013","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.nicl.2018.04.016_bb0240","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.2967\/jnumed.109.064360","article-title":"Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding","volume":"50","author":"Tolboom","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nicl.2018.04.016_bb0245","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.neurobiolaging.2010.04.030","article-title":"Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study","volume":"31","author":"Tosun","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2018.04.016_bb0250","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/nimg.2001.0978","article-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain","volume":"15","author":"Tzourio-Mazoyer","year":"2002","journal-title":"NeuroImage"},{"key":"10.1016\/j.nicl.2018.04.016_bb0255","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e3181af79fb","article-title":"MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change","volume":"73","author":"Vemuri","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2018.04.016_bb0260","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol."}],"container-title":["NeuroImage: Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158218301256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158218301256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:09:16Z","timestamp":1761970156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213158218301256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":52,"alternative-id":["S2213158218301256"],"URL":"https:\/\/doi.org\/10.1016\/j.nicl.2018.04.016","relation":{},"ISSN":["2213-1582"],"issn-type":[{"value":"2213-1582","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nicl.2018.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}